Palbociclib

• Category Breast cancer
• CAS 571190-30-2
• Specification In-house
• US DMF 37586
• CEP / Other DMF N/A
• GMP certification TFDA
• Inspection TFDA
• StatusCompleted process development
• Major Market US, EU,Japan